Early Intervention for Cardiovascular Health
(ENRICH Trial)
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Enriched home visiting for cardiovascular health?
Research shows that home visiting programs, like the ones involving nurses, can improve child and maternal health, enhance parenting, and increase the use of community resources. These programs have been effective in improving outcomes such as child development and maternal mental health, which suggests they could also positively impact cardiovascular health.12345
Is the Early Intervention for Cardiovascular Health treatment safe for humans?
How is the 'Enriched home visiting' treatment unique for promoting cardiovascular health?
The 'Enriched home visiting' treatment is unique because it focuses on early intervention by integrating heart-healthy routines like diet, physical activity, and sleep into the daily lives of mothers and children, aiming to establish lifelong cardiovascular health from a young age. This approach is different from traditional treatments as it emphasizes community and family engagement through home visits, making it a personalized and sustainable strategy for reducing cardiovascular risk.6791011
What is the purpose of this trial?
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) is a cluster randomized clinical trial, funded by the National Heart Lung \& Blood Institute. The study is designed to test the effectiveness of home visiting intervention to promote cardiovascular health and reduce disparities in maternal and early childhood cardiovascular health. Sites, in partnership with evidence-based home visiting programs, are recruiting 6400 participants in total (i.e., 3200 parent-dyads which includes 3200 parents and 3200 children) from diverse community settings with a high burden of cardiovascular disease risk factors.
Eligibility Criteria
This trial is for pregnant individuals enrolled in certain home visiting programs, less than 34 weeks into their pregnancy, and aged 18 or older. They must speak English or Spanish. There are no specific exclusions, so a wide range of people can participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Home visiting intervention to promote cardiovascular health in mothers and children
Follow-up
Participants are monitored for cardiovascular health outcomes after the intervention
Extended Follow-up
Monitoring of child body mass index until 24 months old
Treatment Details
Interventions
- Enriched home visiting
- Routine home visiting
Enriched home visiting is already approved in United States for the following indications:
- Cardiovascular health promotion in mothers and children
- Reduction of disparities in maternal and early childhood cardiovascular health
Find a Clinic Near You
Who Is Running the Clinical Trial?
JHSPH Center for Clinical Trials
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator